← Leaderboards
Pamela Ouyang
Johns Hopkins University
$2,963,906
Attributed
$2,963,906
Total exposure
21
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $391.3K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,963,906 · 21
By mechanism
R01$1,000,315 · 1
U01$732,028 · 1
R21$502,740 · 1
M01$365,926 · 17
N01$362,897 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Jenell S Coleman$4,734,272
- Marguerite Littleton Kearney$3,757,637
- Craig Walter Hendrix$25,690,627
- Ola Arvid Selnes$1,364,915
- Jerilyn K Allen$9,676,793
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectAtherosclerosisHormone TherapyHuman Therapy EvaluationFemaleClinical TrialsAngiographyCoronary BypassPostmenopauseLongitudinal Human StudyPlacebosPathologic ProcessCoronary DisorderWomen'S HealthPostoperative StateCardiovascular Disorder PreventionAntioxidantsVasomotionPlatelet ActivationMedroxyprogesteroneHypertensionMyocardial InfarctionCardiovascular Disorder Risk
Grant awards (39)
Dose Ranging study of the Effects of Alpha Acid on Oxidative Stress$124,740
R21 · FY2010 · AT · contact PI
Dose Ranging study of the Effects of Alpha Acid on Oxidative Stress$189,000
R21 · FY2009 · AT · contact PI
Dose Ranging study of the Effects of Alpha Acid on Oxidative Stress$189,000
R21 · FY2008 · AT · contact PI
TRIAL TO ASSESS CHELATION THERAPY (TACT)$16,730
M01 · FY2007 · RR · contact PI
THE CLEVER STUDY$1,439
M01 · FY2007 · RR · contact PI
THE EFFECT OF STATIN USE ON VASCULAR FUNCTION IN HYPERTENSIVE SUBJECTS$511
M01 · FY2007 · RR · contact PI
PREDICTOR OF ADVANCED SUB-CLINICAL ATHEROSCLEROSIS$206
M01 · FY2007 · RR · contact PI
Serum Sex Hormonoe Levels & Subclinical Atherosclerosis$168,315
R01 · FY2006 · HL · contact PI
TRIAL TO ASSESS CHELATION THERAPY (TACT)$52,172
M01 · FY2006 · RR · contact PI
THE EFFECT OF STATIN USE ON VASCULAR FUNCTION IN HYPERTENSIVE SUBJECTS$12,310
M01 · FY2006 · RR · contact PI
Serum Sex Hormonoe Levels &Subclinical Atherosclerosis$275,500
R01 · FY2005 · HL
TRIAL TO ASSESS CHELATION THERAPY (TACT)$77,447
M01 · FY2005 · RR
THE EFFECT OF STATIN USE ON VASCULAR FUNCTION IN HYPERTENSIVE SUBJECTS$28,744
M01 · FY2005 · RR
DETERMINATION OF THE EFFECT OF HIGH-FAT FOOD ON CORONARY FLOW VELOCITY$8,784
M01 · FY2005 · RR
PREVENTION OF EVENTS WITH ACE INHIBITOR THERAPY (PEACE)$798
M01 · FY2005 · RR
Serum Sex Hormonoe Levels &Subclinical Atherosclerosis$275,250
R01 · FY2004 · HL
Prevention of Events with ACE Inhibitor Therapy (PEACE)$133,921
M01 · FY2004 · RR
Measurement of Coronary Flow Using Transthoracic Echocardiography$27,934
M01 · FY2004 · RR
Determination of the Effect of High-Fat Food on Coronary Flow Velocity$4,930
M01 · FY2004 · RR
Serum Sex Hormone Levels &Subclinical Atherosclerosis$281,250
R01 · FY2003 · HL
WOMEN'S ANGIOGRAPHIC VITAMINS AND ESTROOGENS TRIAL$0
M01 · FY2002 · RR
POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY AFTER CABG$0
M01 · FY2002 · RR
HRt &ATHEROSCLEROSIS AFTER CORONARY BYPASS &MENOPAUSE$0
M01 · FY2002 · RR
HORMONE REPLACEMENT THERAPY EFFECTS ON PROGRESSION OF ARTHEROSCLEROSIS$0
M01 · FY2002 · RR
POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY AFTER CABG$370,606
U01 · FY2001 · HL
HRt &ATHEROSCLEROSIS AFTER CORONARY BYPASS &MENOPAUSE$0
M01 · FY2001 · RR
CLINICAL UNIT FOR THE ANGIOGRAPHIC TRIAL IN WOMEN$0
N01 · FY2001 · HV
WOMEN'S ANGIOGRAPHIC VITAMINS AND ESTROOGENS TRIAL$0
M01 · FY2001 · RR
POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY AFTER CABG$0
M01 · FY2001 · RR
HORMONE REPLACEMENT THERAPY EFFECTS ON PROGRESSION OF ARTHEROSCLEROSIS$0
M01 · FY2001 · RR
CLINICAL UNIT FOR THE ANGIOGRAPHIC TRIAL IN WOMEN$362,897
N01 · FY2000 · HV
POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY AFTER CABG$361,422
U01 · FY2000 · HL
HORMONE REPLACEMENT THERAPY EFFECTS ON PROGRESSION OF ARTHEROSCLEROSIS$0
M01 · FY2000 · RR
PREVENTION OF CARDIAC EVENTS WITH ACE INHIBITORS$0
M01 · FY2000 · RR
PREVENTION OF CARDIAC EVENTS WITH ACE INHIBITORS$0
M01 · FY2000 · RR
PREVENTION OF CARDIAC EVENTS WITH ACE INHIBITORS$0
M01 · FY2000 · RR
WOMEN'S ANGIOGRAPHIC VITAMINS AND ESTROOGENS TRIAL$0
M01 · FY2000 · RR
POSTMENOPAUSAL HRT ON ATHEROSCLEROSIS AFTER CABG$0
M01 · FY2000 · RR
HRt &ATHEROSCLEROSIS AFTER CORONARY BYPASS &MENOPAUSE$0
M01 · FY2000 · RR